Journal of Oncology Pharmacy Practice – A cross-sectional antineoplastic monitoring program is conducted once a year with voluntary Canadian hospital centers, since 2010. Twelve standardized sampling sites were sampled in 109 hospital centers between January 31 and June 18, 2020. Cyclophosphamide and gemcitabine were the drugs most frequently quantified on the surfaces. The armrest of patient treatment chairs, the front grille inside the biological safety cabinet (BSC) and the floor in front of the BSC were frequently contaminated. This large-scale study showed reproducible long term follow up of the contamination of standardized sites of Canadian centers and a reduction in surface contamination from 2010 to 2020.
Subscribe to our newsletters
The CAREX Canada team offers two regular newsletters: the biannual e-Bulletin summarizing information on upcoming webinars, new publications, and updates to estimates and tools; and the monthly Carcinogens in the News, a digest of media articles, government reports, and academic literature related to the carcinogens we’ve classified as important for surveillance in Canada. Sign up for one or both of these newsletters below.